Cleveland Clinic Taussig Cancer Institute

Taussig Cancer Institute is the hub for Cleveland Clinic Cancer Center.


 

NCCN Guidelines Update for TNBC and HER2 Breast Cancer: Immunotherapy and PARP Inhibitors in TNBC & Trastuzumab Biosimilars in HER2 BC

269 views
September 13, 2019
Comments 0
Login to view comments. Click here to Login